# Assessment of the Correlation Between Serum Levels of Adropin and Degree of Severity of Chronic Liver Disease

> **NCT04660409** · NA · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Liver Disease and Cirrhosis

## Interventions

- **DIAGNOSTIC_TEST:** Blood test for serum Adropin

## Key facts

- **NCT ID:** NCT04660409
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-25
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04660409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04660409, "Assessment of the Correlation Between Serum Levels of Adropin and Degree of Severity of Chronic Liver Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04660409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*